Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective. (avaa uuden ikkunan)

Agreda-Vásquez GP, Espinosa-Poblano I, Sánchez-Guerrero SA, Crespo-Solís E, Cabrera-Vásquez S, López-Salmorán J, Barajas J, Peñaloza-Ramírez P, Tirado-Cárdenas N, Velázquez A.

Lähde‎: J Clin Apher 2008;23(5):163-7.

Arkistoitu‎: PubMed 18819155

DOI‎: 10.1002/jca.20175

https://www.ncbi.nlm.nih.gov/pubmed/18819155 (avaa uuden ikkunan)

Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (avaa uuden ikkunan)

Cid J, Ortín X, Elies E, Díaz E.

Lähde‎: Transfus Apher Sci 2003;28(1):101-2.

Arkistoitu‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (avaa uuden ikkunan)

Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature. (avaa uuden ikkunan)

Ellis J, Theodossiou C, Schwarzenberger P.

Lähde‎: Am J Med Sci 1999;318(3):190-3.

Arkistoitu‎: PubMed 10487410

https://www.ncbi.nlm.nih.gov/pubmed/10487410 (avaa uuden ikkunan)

Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium. (avaa uuden ikkunan)

Goss GA, Weinstein R.

Lähde‎: J Clin Apher 1999;14(3):114-21.

Arkistoitu‎: PubMed 10540365

https://www.ncbi.nlm.nih.gov/pubmed/10540365 (avaa uuden ikkunan)

Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis. (avaa uuden ikkunan)

Haupt WF, Rosenow F, van der Ven C, Birkmann C.

Lähde‎: Ther Apher 2000;4(3):195-7.

Arkistoitu‎: PubMed 10910018

https://www.ncbi.nlm.nih.gov/pubmed/10910018 (avaa uuden ikkunan)

Replacement fluids in plasmapheresis: cross-over comparative study. (avaa uuden ikkunan)

Le Conte P, Nicolas F, Adjou C, N'Guyen JM, Billaud E, Moreau P.

Lähde‎: Intensive Care Med 1997;23(3):342-4.

Arkistoitu‎: PubMed 9083239

https://www.ncbi.nlm.nih.gov/pubmed/9083239 (avaa uuden ikkunan)

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. (avaa uuden ikkunan)

Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.

Lähde‎: Ther Apher Dial 2004;8(3):248-53.

Arkistoitu‎: PubMed 15154879

DOI‎: 10.1111/j.1526-0968.2004.00138.x

https://www.ncbi.nlm.nih.gov/pubmed/15154879 (avaa uuden ikkunan)

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. (avaa uuden ikkunan)

Rock G, Sutton DM, Freedman J, Nair RC.

Lähde‎: J Clin Apher 1997;12(4):165-9.

Arkistoitu‎: PubMed 9483177

https://www.ncbi.nlm.nih.gov/pubmed/9483177 (avaa uuden ikkunan)